[Treatment with cardiac electronic implantable devices]

Area of Science:

• Cardiology
• Biomedical Engineering

Background:

• Cardiac device therapy addresses bradyarrhythmia, heart failure, and sudden cardiac death.
• It offers synergistic reverse remodeling and reduces medication side effects in heart failure.
• Cardiac resynchronization therapy (CRT) has significantly improved outcomes for patients with reduced left ventricular ejection fraction (LVEF) and left bundle branch block.

Purpose of the Study:

• To review the advancements and benefits of cardiac device therapy.
• To highlight the role of CRT in improving quality of life and resilience.
• To discuss emerging technologies like conduction system pacing (CSP) and their advantages.

Main Methods:

• Review of current literature on cardiac device therapy.
• Analysis of the impact of CRT on mortality, morbidity, and patient resilience.
• Evaluation of novel pacing techniques and leadless/subcutaneous devices.
• Assessment of infection prevention strategies.

Main Results:

• CRT has revolutionized heart failure management, decreasing mortality and morbidity.
• Conduction system pacing (CSP) offers physiological stimulation, improving heart function and reducing cardiomyopathy risk.
• Leadless pacers and subcutaneous defibrillators provide less invasive options with lower complication rates.
• Pre- and postoperative infection prevention strategies enhance therapy safety.

Conclusions:

• Cardiac device therapy provides crucial treatment options for various cardiac conditions.
• Innovations in CRT, CSP, and leadless/subcutaneous devices are enhancing patient care.
• Minimally invasive approaches and robust infection control are key to improving safety and efficacy.